|
Roy, I am sure sorry to hear about your wife and tell her my prayers
are with her. Several companies are working on therapies that will
attack cancers, and some are after breast cancer specifically. I will
list the ones I like, but you ought to check the biotech topic for
names of others. I like the transgenics companies. There are killer
cells that wipe out cancers, but delivering them to the cancer cell
without them being destroyed first by the immune system is a problem
The transgenic companies are mutating animals to produce products or
cells that will be accepted by the body and allowed to do their healing
work. The leader, IMHO, is Genzyme Transgenics, (GZTC)
with their Frankenstein
goats -g-. Their goat's milk has been genetically altered to human
specs and the prospects look good there. A similar idea but different
approach is the "bloodhound" breast cancer killer cells developed by
Medarex (MEDX). Call them and get a copy of their 1995 annual, which
has a picture of how their Microphage killer cell engulfs and destroys
a breast cancer cell right on the cover and inside cover page. Ciba-
Geigy is their partner, and that is a big name that believes in this
approach. (908) 713-6001. Ligand has the broadest and most promising
product pipeline of any small biotech firm, IMHO. They have several
anti-cancer treatments in Phase II studies right now. I like it for
more than their cancer products, but it is a leader there. British
Biotech is another one I owned until the price got kind of fat, and
they have very promising cancer therapies. Also, look at some of the
larger companies that I don't follow, such as Merck, Pfizer, etc.
Biotech is important, but traditional research gets some great ideas
too. Good luck, MB |
